Brief: Cereno Scientific Q4 Loss SEK 44.7 Mln
27/02/2026 07:13
Feb 27 (Reuters) - Cereno Scientific AB CRNOSb.ST: CERENO SCIENTIFIC Q4 ADJUSTED EPS SEK -0.14 Q4 RESULT AFTER FINANCIAL ITEMS WAS SEK -44 709 850 (-40 262 214) Q4 NET SALES WERE SEK 0 (0) Source text: ID:nWkr19kW8H Further company coverage: [CRNOSb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln